Aug 29 (Reuters) - Paradigm Biopharmaceuticals Ltd PAR.AX :
* FY net loss for the period attributable to members $4.3 million
* FY revenue from continuing activities $1.8 million, up 32.62 percent
Aug 29 (Reuters) - Paradigm Biopharmaceuticals Ltd PAR.AX :
* FY net loss for the period attributable to members $4.3 million
* FY revenue from continuing activities $1.8 million, up 32.62 percent